 CAMBRIDGE, Mass., Oct. 26, 2022 GLOBE NEWSWIRE -- Editas Medicine, Inc. Nasdaq: EDIT, a clinical stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, November 2, 2022, at 8:00 a.m. ET to provide a corporate update and results for the third quarter of 2022. 